News

KemPharm Announces Research Affirming Serdexmethylphenidate’s Lower Potential for Abuse Featured in Peer-Reviewed Publication, Current Medical Research & Opinion

Three clinical studies demonstrated serdexmethylphenidate (SDX), KemPharm’s prodrug of d-methylphenidate (d-MPH), yielded significantly lower abuse-related effects compared to d-MPH CELEBRATION,…

2 years ago

Summit Therapeutics Appoints Ankur Dhingra as Chief Financial Officer

Cambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Ankur Dhingra has been appointed…

2 years ago

Biomea Fusion to Present New Preclinical Data on BMF-219 in Two Diabetic Animal Models at ADA 2022

Company to host virtual investor R&D event on Monday, June 6, 2022 at 4:05 PM EDT featuring covalent menin inhibitor,…

2 years ago

IntelGenx Announces Intention to Issue Shares in Payment of Principal and Interest on Outstanding Debentures

SAINT LAURENT, Quebec, June 01, 2022 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (the “Company” or “IntelGenx”) announces that…

2 years ago

PLx Pharma Inc. to Present at JMP Securities 2022 Life Sciences Conference on June 15, 2022

SPARTA, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug…

2 years ago

SomaLogic Announces June Conference Participation

BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that…

2 years ago

Phathom Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference

FLORHAM PARK, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…

2 years ago

Clearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in India

The patent was granted by India’s Office of the Controller-General of Patents, Designs and Trademarks VANCOUVER, June 01, 2022 (GLOBE…

2 years ago

Akoya Biosciences to Highlight Novel Spatial Transcriptomics Capabilities on PhenoCycler-Fusion at AGBT 2022 Annual Meeting

PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capabilities on a single platformMARLBOROUGH, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Akoya…

2 years ago

Entourage Health Extends its Senior Secured Credit Facility Maturity Date

TORONTO, June 01, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer…

2 years ago